Clostridial necrotising pneumonia is a rare complication of aspiration, bronchial tumour or foreign body, pulmonary infarction, trauma and debilitating medical conditions. Although spontaneous clostridial pneumonia has been reported previously, close scrutiny of those case reports suggests that most of the patients had a recognised predisposing cause. We report a case of true spontaneous Clostridium perfringens pneumonia complicated by septic shock, pneumothorax and pulmonary necrosis. The patient responded poorly to conventional treatment with benzylpenicillin, and although the addition of metronidazole produced dramatic resolution of the sepsis, lobectomy was required to effect cure.
Ventilated asthmatic patients require heavy sedation and may even require paralysis because of their increased respiratory drive. Underlying cardiac disease may pose a particular problem due to the adverse cardiovascular side-effects of bronchodilators. Drugs used for sedation should not worsen bronchospasm and should have minimal effect on preload, afterload and contractility of the myocardium as well as minimal disturbance of oxygen demand/supply ratio. Ketamine in sub-anaesthetic doses has been shown to have the desired sedative effect with no significant cardiovascular side-effects and additionally to have bronchodilating properties. 1 There are several reports of ketamine being successfully used in the management of refractory asthma. '.5. We report a case of refractory asthma complicated by acute myocardial infarction, which responded dramatically to ketamine infusion without cardiovascular side-effects.
CASE HISTORY
A 53-year-old woman with a long history of bronchial asthma was admitted to the medical ward in status asthmaticus. She had suffered from recurrent attacks of bronchial asthma for which she used salbutamol and steroid inhalers, and oral theophylline preparations. For two days prior to admission she had become increasingly breathless and this had not responded to her usual bronchodilator therapy. After admission to the hospital she was treated with nebulised salbutamol 5 mg 6 hrly, aminophylline infusion 750 mg124 hrs, intravenous hydrocortisone 200 mg stat., then 150 mg 6 hrly and antibiotics. The broncho-spasm did not improve, she became confused and after a few hours she was transferred to the intensive care unit (lCU), On arrival in the ICU she was found to have severe bronchospasm with a pulse rate of 140 minute and a blood pressure of 120/80 mmHg, Arterial blood gas analysis while breathing 4 litres/min of oxygen by mask showed a pH of 7.35, PaC02 of 4.69 kPa, and a P a C02 of 7.87 kPa. A chest radiograph excluded any acute lung lesion. Over the next six hours she became increasingly exhausted and agitated, and refused to keep the oxygen mask on. At this stage it was decided to commence mechanical ventilation.
Tracheal intubation was performed using midazolam and suxamethonium, and she was ventilated at a rate of lO/minute with a peak inspiratory flow rate of 30 IIminute and an Fi02 of 0.4.
Subsequently boluses of midazolam and pancuronium were used to control ventilation. The brochospasm remained refractory with a peak inspiratory pressure of over 50 cm H20 and a sinus tachycardia of more than 140/minute. Although there was improvement in oxygenation (P a 02 12.06 kPa) it was difficult to correct the mild hypercapnia which remained at approximately 6.56 kPa. The serum aminophylline level was within therapeutic range on infusion of 750 mg of aminophylline124 hrs. On the second day in the ICU she was found to have sustained acute anteroseptal myocardial infarction with deep Q waves and ST segment elevation in the anterior chest leads and a marked rise in cardiac enzymes including creatine kinase-MB which was elevated to 650 lU/l (n= <8). Midazolam infusion for three days failed to produce satisfactory sedation. Propofol infusion at 2 mg/kg/hr with intermittent boluses of midazolam also failed to achieve adequate sedation. After six days she still had severe bronchospasm, tachycardia, profuse sweating and hypercapnia (PaC02 6.5-7 kPa) with satisfactory oxygenation despite IPPV and continued maximum bronchodilator and steroid therapy. There was no clinical or radiological evidence of left ventricular failure.
At this stage a low-dose ketamine infusion was commenced. This was initiated by a bolus of ketamine 20 mg followed by a continuous infusion at a rate of 20 mg/hr (5 micrograms/kg/minute). Midazolam 5 mg was continued in 4-hourly boluses. After one hour the rate of infusion of ketamine was increased to 30 mg/hr for three hours and subsequently maintained at 20 mg/hr. Remarkable improvement was noted in her general condition with a decrease in pulse rate to 100-11O/minute within two hours of initiation of therapy. She stopped perspiring and the audible wheeze disappeared. Blood gas analysis showed improved gas exchange with a P a 02 of 13.9 kPa, P a C02 of 4.5 kPa and pH 7.4. The rate of ketamine infusion was decreased to 10 mg/hr. After 18 hours of ketamine infusion she was sleepy but rousable and was weaned off the ventilator without difficulty. She continued to improve and was discharged to the ward on the third day after extubation and was discharged home two weeks later.
DISCUSSION
Ketamine hydrochloride has been in use as a dissociative anaesthetic agent since the late 1960s. Early experience suggested that ketamine was a safe induction agent in critically ill and elderly patients as it provided a better safety margin than conventional anaesthesia. It does however cause a dose-related rise in ratepressure product through centrally mediated sympathomimetic effects. 6 Ketamine directly dilates vascular smooth muscle including the coronary arteries, while causing sympathomimetically mediated vasoconstriction; the net effect is that the peripheral resistance is not significantly altered. 7 The unwanted cardiovascular and psycho mimetic side-effects are minimised by using ketamine as a continuous infusion of 10-30 micrograms/kg/minute. I Pretreatment with central nervous system depressants such as barbiturates and benzodiazepines has also been shown to attenuate these unwanted side-effects. In sub anaesthetic doses ketamine has been shown to have an inotropic effect and also anti-arrhythmic properties by prolonging the effective refractory period,9 and it has been successfully used in paediatric catheterisation procedures. 10 In a study comparing morphine and diazepam with nitrous oxide and ketamine for coronary bypass surgery, no significant difference was found in perioperative morbidity and mortality. 11 Ketamine also produces analgesia, which may be mediated through interaction with sigma receptors. Infusion of ketamine at a rate of 4 micrograms/kg/minute produces analgesia comparable to that from morphine 33 micrograms/kg/minute. 12 More importantly ketamine has marked beneficial effects on airway resistance. It reduces airway resistance and increases pulmonary compliance by its betasympathomimetic effects. It also improves oxygenation by preserving reflex hypoxic vasoconstriction. Ketamine antagonises antigen-induced bronchospasm which may be due to its vagolytic and direct smooth muscle relaxant effects. Because of these effects it is regarded as the drug of choice for anaesthetising patients with bronchospasm and bronchospastic disorders and is superior to both ether and halothane. 2 Low-dose ketamine infusion has been used in the management of patients with refractory asthma in intensive care who were intubated and ventilated. 24 Strube et al avoided tracheal intubation in a spontaneously breathing patient. 5 Our usual practice to provide sedation in nonsurgical patients is to use a continuous infusion of midazolam supplemented by boluses of either midazolam or opioids. Papaveretum was avoided in our patient because of its histamine-releasing property. Adequate sedation could not be achieved in our patient with either midazolam alone or in combination with propofol.
It was therefore decided to use a ketamine infusion in this patient despite acute myocardial infarction. The low-dose infusion produced a dramatic improvement in respiratory mechanics without any adverse effect on the cardiovascular system. This case highlights the efficacy of ketamine as an effective adjuvant to standard bronchodilator therapy in the management of refractory asthma and the cardiovascular safety even in the presence of acute myocardial injury.
His blood white cell count was 14.1 x 10 9 11. Haemoglobin, serum creatinine and electrolytes and liver function tests were normal. Cultures of blood taken on admission were sterile.
Initial treatment was with intravenous fluids, analgesia, intravenous benzylpenicillin (l.2g 4 hourly) and erythromycin (l.Og 6 hourly). Due to rapidly progressive dyspnoea he was admitted to the Intensive Care Unit (ICU).
Two hours after admission to ICV the patient became vasodilated, hypotensive, oliguric and increasingly hypoxic. The hypotension and oliguria responded to vigorous fluid resuscitation, but the hypoxia was refractory to high flow mask oxygen and mechanical ventilation was therefore instituted. Immediately following intubation, blood stained sputum was suctioned from the trachea. The following day, the patient developed a left pneumothorax which required tube drainage. A subsequent chest X-ray ( Figure I) showed a gas shadow behind the heart suggestive of a lower lobe abscess. At bronchoscopy large amounts of haemorrhagic sputum were again aspirated, which unexpectedly yielded a pure growth of Clostridium perfringens, sensitive, by an agar incorporation method (penicillin 8~g/ml and metronidazole 8~g/ml), to both benzylpenicillin and metronid-
